Point-of-Care Detection of Carcinoembryonic Antigen (CEA) Using a Smartphone-Based, Label-Free Electrochemical Immunosensor with Multilayer CuONPs/CNTs/GO on a Disposable Screen-Printed Electrode
2024

Smartphone-Based Immunosensor for Cancer Detection

publication Evidence: high

Author Information

Author(s): Khonyoung Supada, Mangkronkaew Praphatsorn, Klayprasert Puttaporn, Puangpila Chanida, Palanisami Muthukumaran, Arivazhagan Mani, Jakmunee Jaroon

Primary Institution: Thammasat University, Thailand

Hypothesis

Can a smartphone-based, label-free electrochemical immunosensor effectively detect carcinoembryonic antigen (CEA) in serum samples?

Conclusion

The developed immunosensor can accurately detect low levels of CEA in serum, making it a promising tool for early cancer diagnosis.

Supporting Evidence

  • The immunosensor showed a linear detection range of 0.1–5.0 ng mL−1 for CEA.
  • It achieved a low detection limit of 0.08 ng mL−1, which is below the normal CEA level.
  • The sensor demonstrated high selectivity and reproducibility in detecting CEA.
  • Recovery rates for CEA detection in serum samples ranged from 101% to 112%.

Takeaway

This study created a small device that can quickly check for cancer markers in blood using a smartphone, which is easy to use and doesn't need extra labels.

Methodology

The immunosensor was constructed using a layer-by-layer assembly of nanostructured materials on a screen-printed carbon electrode, allowing for direct detection of CEA without additional labeling.

Limitations

The immunosensor currently detects only one biomarker, which may limit its application in comprehensive cancer diagnostics.

Statistical Information

P-Value

0.08 ng mL−1

Digital Object Identifier (DOI)

10.3390/bios14120600

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication